V

ViroGates A/S
CSE:VIRO

Watchlist Manager
ViroGates A/S
CSE:VIRO
Watchlist
Price: 15.4 DKK -6.67% Market Closed
Market Cap: 119.1m DKK
Have any thoughts about
ViroGates A/S?
Write Note

ViroGates A/S
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ViroGates A/S
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
V
ViroGates A/S
CSE:VIRO
Free Cash Flow
-kr12m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GN Store Nord A/S
CSE:GN
Free Cash Flow
kr1.7B
CAGR 3-Years
2%
CAGR 5-Years
10%
CAGR 10-Years
13%
Ambu A/S
CSE:AMBU B
Free Cash Flow
kr524m
CAGR 3-Years
N/A
CAGR 5-Years
14%
CAGR 10-Years
N/A
Demant A/S
CSE:DEMANT
Free Cash Flow
kr3B
CAGR 3-Years
1%
CAGR 5-Years
19%
CAGR 10-Years
14%
No Stocks Found

ViroGates A/S
Glance View

Market Cap
119.1m DKK
Industry
Health Care

ViroGates A/S develops and markets prognostic products for the healthcare sector. Its develops a product line suPARnostic, which measures the amount of amount of soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The plasma level of suPAR reflects immune activation and is increased in such infectious diseases as HIV-1-infection, malaria, tuberculosis, Streptococcus pneumonia bacteraemia, sepsis, pneumococcal pneumonia and bacterial and viral CNS infection. Also, high suPAR levels are associated with increased inflammation, disease progression and risk of mortality. Thus, measuring suPAR levels serves as a marker to determine chances for survival upon hospital admission, as well as for monitoring for prevention of disease progression and earlier intervention time point. suPARnostic has two versions: Quantitative Point of Care Quick Triage test, which serves for patient triage in acute care, and Quantitative ELISA Assay that aims at clinical routine use.

VIRO Intrinsic Value
3.42 DKK
Overvaluation 78%
Intrinsic Value
Price
V

See Also

What is ViroGates A/S's Free Cash Flow?
Free Cash Flow
-12m DKK

Based on the financial report for Sep 30, 2024, ViroGates A/S's Free Cash Flow amounts to -12m DKK.

What is ViroGates A/S's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
20%

Over the last year, the Free Cash Flow growth was -20%. The average annual Free Cash Flow growth rates for ViroGates A/S have been 20% over the past three years .

Back to Top